This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Li Tian - Innovator in Sulfonamide Pharmaceutical Composition
Introduction
Li Tian is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on sulfonamide compounds. His expertise and dedication to research have led to the development of a unique injectable preparation that enhances the effectiveness of sulfonamide treatments.
Latest Patents
Li Tian holds 1 patent for his invention titled "Sulfonamide Pharmaceutical Composition." This patent describes a sulfonamide compound injectable preparation that includes a sulfonamide compound or its derivative. The preparation is created using a pharmaceutically acceptable carrier and specific preparation technologies. The resulting injectable preparation is noted for its stability, quality control, and effectiveness in medical applications.
Career Highlights
Li Tian is associated with Tianjin Hongri Jian Da Kang Medical Technology Co., Ltd., where he applies his knowledge and skills to advance pharmaceutical technologies. His work has been instrumental in developing new medical solutions that benefit patients and healthcare providers alike.
Collaborations
Li Tian collaborates with talented professionals in his field, including Xiaoqing Yao and Xinying Zhao. Their combined efforts contribute to the innovative projects at their company, fostering a collaborative environment that encourages creativity and scientific advancement.
Conclusion
Li Tian's contributions to the pharmaceutical industry, particularly through his sulfonamide pharmaceutical composition, highlight his role as an innovator. His work not only advances medical technology but also improves patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile